Ajanta Pharmaceuticals Ltd (AJANTPHARM)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 2555.00
% Change: -0.87% (Prev Close: 2577.50)

Volume: 27,521
% Change: -18.63% (Prev Volume: 33,822)

Delivery: 15,209
Delivery % : 55.26
% Change: -2.58% (Prev Delivery: 15,612)

Turnover: 706 Lacs
% Change: -19.43% (Prev Turnover: 877)

πŸ’Ή EOD Valuation

P/E Ratio: 34.32
P/B Ratio: 8.42
Market Cap: 31912 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AJANTPHARM
Market Cap: 30954 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 3485.75
52 Week Low: 2022.05

All-Time High: 3485.75 Rs.
All-Time Low: 4.03 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-2.97% | -0.54% | -0.21% | -20.81% | 23.85%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 66.26%

Change (3Y | 1Y): -4.22% | 0.00%

Pledged %: 14.43%

FII Holding

FII Holding: 8.86%

Change (3Y | 1Y): 0.56% | 0.00%

DII Holding

DII Holding: 17.50%

Change (3Y | 1Y): 5.04% | 0.02%

Public Holding: 7.38%

🏦 Financial Strength

Debt to Equity: 0.01
Debt: 47.42 Rs. Cr.

Book Value: 303.44 Rs.
Current Ratio: 2.41
Interest Coverage: 48.43
Free Cash Flow: 840.45 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 10.92%

Sales Growth Qtr (YOY | QoQ):
13.78% | 11.30%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
12.43% | 11.63% | 10.92%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 8.92%

Profit Growth Qtr (YOY | QoQ):
3.89% | 13.35%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
14.26% | 8.71% | 8.92%

EPS Rs.

EPS (TTM): 74.45 Rs.

EPS Qtr (Last Year | Latest):
19.68 Rs. | 20.44 Rs.

EPS Annual (Last Annual | Annual March):
63.70 Rs. | 73.68 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
15.34% | 9.63%

Net Profit Rs. Cr.

Net Profit (TTM): 929.96 Rs. Cr.

Net Profit (Annual - March): 920.39 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
245.77| 225.26 | 255.34

EBITDA Rs. Cr.

EBITDA (Quarter): 377.68 Rs. Cr.
EBITDA (Previous Yr Ql): 356.82 Rs. Cr.

EBITDA (Annual - March): 1348.43 Rs. Cr.
EBITDA (Previous Annual): 1245.42 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
11.70% | 8.84%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 26.64%

OPM Qtr (Previous | Current):
25.39% | 26.97%

OPM Annual (5 Yrs | Last Yr | March):
27.53% | 27.85% | 27.30%

Return on Equity %

ROE: 24.91%

ROE (5 Yrs | 3 Yrs | Last Yr):
22.44% | 22.12% | 23.23%

Return on Capital Employed %

ROCE: 32.37%

ROCE (5 Yrs | 3 Yrs | Last Yr):
29.49% | 28.86% | 31.60%

Return on Assets %

ROA (TTM): 19.43%

ROA (5 Yrs | 3 Yrs | Last Yr):
17.60% | 17.00% | 17.74%

PEG Ratio: 3.82
Dividend Yield: 1.13%

PE 3 Yrs: 36.13
PE 5 Yrs: 28.31

Dividend Yield: 1.13%

πŸ‘₯ Company

Ajanta Pharmaceuticals Ltd

AJANTPHARM

Promoter Holding: %